Tanios S. Bekaii-Saab, MD, Mayo Clinic

Articles

Treatments for BRAF-Mutated mCRC

April 16th 2021

Considerations for treating BRAF-mutated metastatic colorectal cancer with the combination of a BRAF inhibitor plus anti-EGFR agent based on recently presented data.

Second-Line Treatment of mCRC: Rechallenging Therapy

April 16th 2021

The role of molecular assays, including liquid biopsies, in providing information on resistance mechanisms in metastatic colorectal cancer and the impact of testing results on decisions for rechallenging with a previous therapy.

Preferences for Second-Line Therapy for mCRC

April 9th 2021

Drs Cathy Eng and Joleen M. Hubbard explain how patients with metastatic colon cancer typically respond to initial treatment and describe the factors that impact second-line treatment decisions.

Maintenance Therapy for Metastatic CRC

April 9th 2021

Recommendations regarding the selection, initiation, and length of maintenance therapy to help manage cases of metastatic colon cancer.

Optimizing mCRC Treatment: Decision-Making With Patients

March 25th 2021

An overview of topics that oncologists should counsel patients on when working with them to select therapy to treat metastatic colon cancer.

Initial Strategies for Assessing and Treating mCRC

March 25th 2021

Experts in gastrointestinal oncology highlight their approaches to assessing patients with newly diagnosed metastatic colorectal cancer and explain the variables that factor into first-line treatment decisions.

Future of NTRK Fusions

May 21st 2020

Challenges for TRK Fusion–Targeting Agents

May 21st 2020

Acquired Resistance in TRK Fusion-Positive Cancers

May 21st 2020

Approaching Treatment for TRK Fusion–Positive Cancers

May 21st 2020

TRK Inhibitor in GI Cancers: Adverse Effect Profile

May 21st 2020

Efficacy of TRK Inhibitors

May 21st 2020

Early Development of TRK Inhibitors

May 21st 2020

Advice for Interpreting NGS Reports

May 21st 2020

Driver Mutations in NTRK Fusion-Positive Cancers

May 21st 2020

Genomic Testing for NTRK Fusions in Lung and GI Cancers

May 21st 2020

Approaching Genomic Testing for NTRK Fusions

May 21st 2020

Using Molecular Testing in GI Cancers

May 21st 2020

Evolution of NGS Testing in Lung Cancers

May 21st 2020

Variants of NTRK Fusions in Solid Tumors

May 21st 2020